Pathway to a vaccine : efforts to develop a safe, effective and accessible COVID-19 vaccine : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, second session, July 21, 2020.

Format:

Book

Government document

Author/Creator:

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author.

Language:

English

Subjects (All):

COVID-19 (Disease)--United States.

COVID-19 (Disease).

Vaccines--United States.

Vaccines.

Genre:

Legislative hearings.

Physical Description:

1 online resource (v, 131 pages)

Other Title:

Efforts to develop a safe, effective and accessible COVID-19 vaccine

Place of Publication:

Washington : U.S. Government Publishing Office, 2024.

Participant:

Hearing witnesses: Menelas Pangalos, Ph.D., Executive Vice President, Biopharmaceuticals R & D, AstraZeneca; MaCaya Douoguih, M.D., MPH, Head of Clinical Development and Medical Affairs, Janssen Vaccines, Johnson & Johnson; Julie L. Gerberding, M.D., MPH, Executive Vice President and Chief Patient Officer, Merck; Stephen Hoge, M.D., President, Moderna; John Young, Chief Business Officer, Pfizer.

Notes:

Associated bill citation(s): H.R. 7104.

"Serial no. 116-121."

Includes bibliographical references.

Date of hearing: 2020-07-21.

Description based on online resource, PDF version; title from title page (GovInfo, viewed July 29, 2024).

In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).

Other Format:

Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Pathway to a vaccine

OCLC:

1450320110

Publisher Number:

55-508 (GPO jacket number)